Better renal replacement therapy to improve sexual function in female patients with end-stage renal disease: A cross-sectional study

Abstract

Background: Sexual dysfunction is commonly observed in patients with end-stage renal disease (ESRD). Sexual dysfunction in correlation with ESRD is associated with physiological and psychological problems resulting in low sexual desire, arousal, difficulties in achieving orgasm, and pain during intercourse. Studies on female sexual dysfunction (FSD) in correlation with renal replacement therapy are limited, and previous studies reporting contradictive results have indicated that the best modality for providing better outcomes (especially on FSD) remains unclear. Thus, this study aimed to compare the sexual function between female patients with ESRD who were on continuous ambulatory peritoneal dialysis (CAPD) and those on hemodialysis (HD).

Materials and methods: This study enrolled female patients who were randomly selected from the urology and renal division of the Internal Medicine Outpatient Clinic of our hospital from January 2020 to August 2021 and divided into the following groups: predialysis, HD, CAPD, and control groups. The participants were asked to fill out the Female Sexual Function Index (FSFI) questionnaires, and their data were recorded and analyzed using GraphPad Prism 9.0.0.

Results: Of the 280 patients, 200 female patients were included in this study. The rate of FSD (cutoff: 26.55) was 42% in the control group, 72% in the predialysis group, 62% in the CAPD group, and 66% the in HD group. The control group had a higher mean score in all parameters (p < 0.05). The total FSFI mean score indicated no significant difference (p > 0.05) between the patients on HD and those on CAPD; the mean of each point was almost identical except for satisfaction, which was higher among patients on CAPD (p < 0.05). Significant differences in the components of desire, arousal, orgasm, and satisfaction were observed between the groups.

Conclusions: Patients on CAPD had better FSFI scores than the female patients with ESRD who were on HD, and the scores of both groups of patients were better than those of the predialysis group.

Keywords

Female sexual dysfunction / Chronic kidney disease / Continuous ambulatory peritoneal dialysis / Hemodialysis

Acknowledgments

None.

Statement of ethics

This study was approved by our hospital ethical committee with letter number LB.02.01/X.6.5/513/2022, and all the patients provided written consent for data publication. All data were collected and analyzed anonymously. All the procedures performed involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Conflict of interest statement

The authors declare that they have no conflicts of interest

Funding source

None.

Author contributions

TT: Project development, data analysis, manuscript writing;

SS: Data collection, data analysis, manuscript writing.

Data availability

The datasets generated during and/or analyzed during the current study are not publicly available, but are available from the corresponding author on reasonable request.

References

[1] Yazici R, Altintepe L, Guney I, et al. Female sexual dysfunction in peritoneal dialysis and hemodialysis patients. Ren Fail 2009; 31(5):360-364.

[2] Finkelstein FO, Shirani S, Wuerth D, Finkelstein SH. Therapy insight: Sexual dysfunction in patients with chronic kidney disease. Nat Clin Pract Nephrol 2007; 3(4):200-207.

[3] Harrison TG, Skrtic M, Verdin NE, Lanktree MB, Elliott MJ. Improving sexual function in people with chronic kidney disease: A narrative review of an unmet need in nephrology research. Can J Kidney Health Dis 2020;7:2054358120952202.

[4] Peng YS, Chiang CK, Kao TW, et al. Sexual dysfunction in female hemodialysis patients: A multicenter study. Kidney Int 2005; 68(2):760-765.

[5] Basok EK, Atsu N, Rifaioglu MM, Kantarci G, Yildirim A, Tokuc R. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients. Int Urol Nephrol 2009; 41(3):473-481.

[6] Agarwal R. Defining end-stage renal disease in clinical trials: A framework for adjudication. Nephrol Dial Transplant 2016; 31(6):864-867.

[7] Boulet MJ, Oddens BJ, Lehert P, Vemer HM, Visser A. Climacteric and menopause in seven South-east Asian countries. Maturitas 1994; 19(3):157-176.

[8] Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26(2):191-208.

[9] Strippoli GF, Vecchio M, et al; Collaborative Depression and Sexual Dysfunction (CDS) in Hemodialysis Working Group. Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol 2012; 7(6):974-981.

[10] Pangastuti N, Santoso BI, Agustiningsih D, Emilia O. Validation test of Indonesian female sexual function index (Indonesian FSFI). Bali Med J 2019; 8(1):164-168.

[11] Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications. J Urol 2000; 163(3):888-893.

[12] Bartula I, Sherman KA. Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC). Breast Cancer Res Treat 2015; 152(3):477-488.

[13] Pyrgidis N, Mykoniatis I, Tishukov M, et al. Sexual dysfunction in women with end-stage renal disease: A systematic review and meta-analysis. J Sex Med 2021; 18(5):936-945.

[14] Palmer BF. Sexual dysfunction in uremia. J Am Soc Nephrol 1999; 10(6):1381-1388.

[15] Koca TG, Koca N, Ersoy A. The comparison of the relationship between sociocultural-economic features and sexual dysfunction frequency in sexually active premenopausal female patients on renal replacement therapy. J Sex Med 2012; 9(12):3171-3179.

[16] Lew-Starowicz M, Gellert R. The sexuality and quality of life of hemodialyzed patients—ASED multicenter study. J Sex Med 2009; 6(4):1062-1071.

[17] Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 2010; 22(3):179-184.

[18] Levin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC. The physiology of female sexual function and the pathophysiology of female sexual dysfunction (Committee 13A). J Sex Med 2016; 13(5):733-759.

[19] Guven S, Sari F, Inci A, Cetinkaya R. Sexual dysfunction is associated with depression and anxiety in patients with predialytic chronic kidney disease. Eurasian J Med 2018; 50(2):75-80.

[20] Jung HY, Jeon Y, Park Y, et al. Better quality of life of peritoneal dialysis compared to hemodialysis over a two-year period after dialysis initiation. Sci Rep 2019; 9(1):10266.

[21] Duarsa GWK, Kandarini Y, Luciana L, et al. Sexual dysfunction reduction in female patients with chronic kidney disease undergoing continuous ambulatory peritoneal dialysis. Acta Med Indones 2020; 52(4):360-365.

[22] Hou S. Pregnancy in women treated with dialysis: Lessons from a large series over 20 years. Am J Kidney Dis 2010; 56(1):5-6.

[23] Bass A, Ahmed SB, Klarenbach S, Culleton B, Hemmelgarn BR, Manns B. The impact of nocturnal hemodialysis on sexual function. BMC Nephrol 2012;13:67.

[24] Mor MK, Sevick MA, Shields AM, et al. Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis. Clin J Am Soc Nephrol 2014; 9(1):128-134.

[25] Soykan A, Boztas H, Kutlay S, et al. Do sexual dysfunctions get better during dialysis? Results of a six-month prospective follow-up study from Turkey. Int J Impot Res 2005; 17(4):359-363.

[26] Lo JC, Beck GJ, Kaysen GA, et al. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int 2017; 21(2):190-196.

[27] Filocamo MT, Zanazzi M, Li Marzi V, et al. Sexual dysfunction in women during dialysis and after renal transplantation. J Sex Med 2009; 6(11):3125-3131.

[28] Makkar V, Kumar M, Mahajan R, Khaira NS. Comparison of outcomes and quality of life between hemodialysis and peritoneal dialysis patients in Indian ESRD population. J Clin Diagn Res 2015; 9(3):OC28-OC31.

[29] Dhondt A, Vanholder R, Van Biesen W, Lameire N. The removal of uremic toxins. Kidney Int Suppl 2000;76:S47-S59.